Skip to content

Comparing the effect of Daruharidra and Amalaki beej in Shwetapradara (abnormal vaginal discharge)

Randomised comparitive clinical study to evaluate the efficacy of Daruharidra and Amalaki Beej in Shwetapradara w.s.r to abnormal vaginal discharge - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085532
Enrollment
60
Registered
2025-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N768- Other specified inflammation of vagina and vulva

Interventions

None listed

Sponsors

Madan Mohan Malviya Government Ayurved College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients with signs and symptoms of shwetapradara (abnormal vaginal discharge) Age between 18 to 50 female patient Female who are willing to participate

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Patients with known history of STD Abnormal uterine bleeding vaginal discharge occurring due to intrauterine contraceptive device Patients with Oral Contraceptive PillS Patients with ca cervix and other gynacological problems like ovarian cyst, uterine prolapse, uterine fibromyoma etc 5)Patients with Oral Contraceptive PillS 6) Patients with ca cervix and other gynacological problems like ovarian cyst, uterine prolapse, uterine fibromyoma, etc

Design outcomes

Primary

MeasureTime frame
Changes in the signs and symptoms of sveta pradara (Abnormal vaginal discharge) - Yonigata sravah, varna, vedana, kandu, katishula, dourbalya, mutradaha, consistency of vaginal discharge, yoni dourgandhya, vaginal phTimepoint: 60 days

Secondary

MeasureTime frame
identification & authentication of drugsTimepoint: 15 days, 30days, 45days,60 days

Countries

India

Contacts

Public ContactDr Karishma Bhadra

Madan Mohan Malviya Government Ayurved College

drashwinisharma1972@gmail.com9929093470

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026